Evidence map›Paper›PMID 31871477›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Effects of Traditional Kampo Drugs and Their Constituent Crude Drugs on Influenza Virus Replication

Toshihito Nomura, Masaya Fukushi, Kosuke Oda, Akifumi Higashiura, Takashi Irie, Takemasa Sakaguchi

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Which East Asian herbal medicines can decrease viral infections?Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2022
    Review
  2. Frontiers in pharmacology · 2022
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. The use ofAvicenna journal of phytomedicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Toshihito NomuraDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Masaya FukushiDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kosuke OdaDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Akifumi HigashiuraDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takashi IrieDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takemasa SakaguchiDepartment of Virology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.ORCID https://orcid.org/0000-0002-3754-1252
Hiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An influenza virus epidemic is an important issue in public hygiene, and continuous development on an effective drug is required. Kampo medicine is a traditional medicine that is used clinically for treatment of various diseases in Japan and other East Asian countries. We evaluated the effects of the Kampo drugs maoto, kakkonto, senkyuchachosan, jinkokato, and bakumondoto, which are prescribed for treatment of respiratory symptoms including symptoms caused by influenza, on influenza virus replication in cultured cells. Culture media of influenza virus-infected MDCK(+) cells were tested for hemagglutination and infectivity at 24 h after the addition of Kampo drugs at various concentrations, and four of the five Kampo drugs were found to inhibit virus release to the culture media. These drugs inactivated virus infectivity not by acting on virus particles but by acting on virus-infected cells. In addition, when six crude drugs (

Identifiers

PMID31871477
PMCPMC6913311
OpenAlexW2992697258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.